Novartis India Ltd.

Web: novartis.in NSE: NOVARTIND BSE: 500672 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1656 42(3%)

Near 52W High of 1780

Volume

17k as on 23, Jun

Open

955

High

975

Low

955

1,614

VWAP

1,495

52 Week High

1,780

52 Week Low

950

Viand Research Rating

Quality Score

12/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,089

No. of Shares

2.47

P/E

29.83

P/B

3.57

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.98

ROCE

Profit Growth

Listing Date

Promoter Holding

70.68%

FII Holding

0.17%

DII Holding

0.53%

Price Chart

Price Performance

1 Week11%

1 Month8%

3 Months48%

6 Months48%

1 Year48%

YTD48%

Moving Average

5 Day SMA1,417

10 Day SMA1,365

20 Day SMA1,392

30 Day SMA1,351

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,674	1,527	1,597	1,709
Resistance 2	1,597	1,516	1,547	1,614
Resistance 1	1,544	1,504	1,516	1,579
Pivot Point	1,467	1,492	1,467	1,484
Support 1	1,414	1,480	1,417	1,449
Support 2	1,336	1,468	1,386	1,354
Support 3	1,284	1,456	1,336	1,318

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%	(0.01) 70.68%
FIIs	(0.01) 0.17%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(0.01) 0.19%	(-0.11) 0.19%	(0.11) 0.32%	(0.11) 0.23%	(0.01) 0.17%	(0.01) 0.17%	(0.01) 0.17%	(0.01) 0.14%	(0.01) 0.12%	(0.01) 0.09%
DIIs	(-0.11) 0.53%	(0.11) 0.63%	(0.01) 0.53%	(0.01) 0.53%	(0.01) 0.53%	(0.01) 0.53%	(0.01) 0.52%	(0.01) 0.52%	(0.01) 0.52%	(0.01) 0.52%	(-0.21) 0.52%	(0.01) 0.75%	(0.01) 0.77%	(0.01) 0.77%	(0.01) 0.77%	(0.01) 0.78%	(0.01) 0.77%	(0.01) 0.78%
Public	28.60%	28.50%	28.61%	28.60%	28.61%	28.60%	28.61%	28.60%	28.61%	28.60%	28.47%	28.34%	28.38%	28.37%	28.37%	28.41%	28.43%	28.46%
No. of Shareholders	38,116	39,468	39,353	39,040	39,133	38,926	39,596	39,265	41,239	43,128	43,992	43,343	41,947	42,622	43,275	43,996	44,371	44,640

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	91	86	90	88	84	93	87	92	81	85	79	91	76	80	102	121	98	99	104
Sales Growth % (YoY)	-	-7.6%	3.7%	-5.1%	3.3%	10%	10.6%	1.9%	6.6%	5.4%	-22.4%	-25.1%	-22.6%	-19%	-2.8%	23.2%	-1%	5.5%	9%
Sales Growth % (QoQ)	5.8%	-4.4%	2.3%	4.8%	-9.7%	6.9%	-5.4%	13.6%	-4.7%	7.6%	-13.2%	19.7%	-5%	-21.6%	-15.7%	23.5%	-1%	-4.8%	-
Expenses	70	64	66	60	60	67	69	68	70	65	62	73	67	73	85	89	93	92	97
Operating Profit	21	22	24	27	24	26	18	24	11	20	17	17	9	8	16	32	6	7	7
OPM %	23	26	26	31	29	28	21	26	14	23	21	19	12	10	16	26	6	7	7
Other Income	10	9	9	11	11	11	10	10	10	22	17	12	16	8	7	27	-35	6	6
Interest	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	2
Depreciation	0	0	1	1	1	1	1	1	0	0	1	2	2	1	1	1	1	3	3
Profit before tax	30	30	33	37	34	35	28	34	21	41	32	28	23	14	21	57	-31	8	9
Tax %	16	46	26	26	14	28	26	24	31	36	27	27	-7	47	14	7	-25	24	24
Net Profit	25	16	24	28	29	25	20	26	15	27	24	20	25	8	18	52	-23	6	7
Net Profit Growth % (QoQ)	56.2%	-33.3%	-14.3%	-3.4%	16%	25%	-23.1%	73.3%	-44.4%	12.5%	20%	-20%	212.5%	-55.6%	-65.4%	326.1%	-483.3%	-14.3%	-
Net Profit Growth % (YoY)	-13.8%	-36%	20%	7.7%	93.3%	-7.4%	-16.7%	30%	-40%	237.5%	33.3%	-61.5%	208.7%	33.3%	157.1%	-	-	-	-
TTM Net Profit	93	97	106	102	100	86	88	92	86	96	77	71	103	55	53	42	-10	13	0
EPS in Rs	10.23	6.52	9.81	11.19	11.87	10.31	8.27	10.42	5.95	10.76	9.59	8.21	10.13	3.08	7.43	21.21	-9.47	2.57	2.84

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	354	356	335	379	400	381	438	491	564	656	690	870	859	901
Sales Growth %	-	6.3%	-11.5%	-5.3%	4.9%	-13%	-10.7%	-13%	-14.1%	-4.9%	-20.8%	1.3%	-4.6%	7%
Expenses	260	265	270	314	373	355	426	478	570	631	656	874	861	810
Operating Profit	94	91	65	65	27	27	12	12	-6	25	34	-4	-1	90
OPM %	27	26	19	17	7	7	3	2	-1	4	5	0	0	10
Other Income	39	42	62	58	-17	33	36	78	172	71	207	101	95	83
Interest	1	1	1	2	5	8	6	2	6	1	0	0	0	0
Depreciation	2	2	3	6	10	12	13	3	3	4	3	4	4	4
Profit before tax	130	130	123	115	-4	40	29	86	158	92	237	93	90	169
Tax %	28	23	31	10	-3	48	65	40	50	38	16	15	-10	29
Net Profit	93	101	85	103	-4	21	10	52	78	57	198	79	99	120
Net Profit Growth %	-7.9%	18.8%	-17.5%	2675%	-119%	110%	-80.8%	-33.3%	36.8%	-71.2%	150.6%	-20.2%	-17.5%	-
EPS in Rs	37.74	40.87	34.5	41.86	-1.51	8.46	4.08	20.97	31.74	20.33	62.04	24.75	30.83	37.46
Dividend Payout %	0	61	72	113	-663	118	245	48	32	49	16	40	32	27

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	75	113	45	39	-69	-23	-194	161	-41	57	-60	-5	7
Cash from Investing Activity	-3	33	-153	87	95	56	274	69	424	-630	719	22	-16
Cash from Financing Activity	-64	-121	-30	-36	-37	-41	-30	-268	-332	-39	-38	-38	-37
Net Cash Flow	7	26	-139	90	-11	-9	50	-38	51	-612	622	-20	-46

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	12	12	12	12	12	12	12	12	12	12	12	14	16	16	16	16
Reserves	805	763	773	717	732	763	679	699	708	747	721	906	1178	986	945	884
Borrowings	3	4	5	6	7	22	24	62	68	0	0	0	0	0	0	0
Other Liabilities	157	153	158	156	173	186	242	229	289	223	377	230	239	244	241	241
Total Liabilities	978	932	948	891	925	983	958	1002	1078	982	1111	1150	1433	1246	1202	1141
Fixed Assets	3	4	5	6	7	19	24	64	76	15	5	6	6	8	8	10
CWIP	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	975	928	943	885	918	964	934	938	1001	967	1106	1144	1426	1238	1194	1131
Total Assets	978	932	948	891	925	983	958	1002	1078	982	1111	1150	1433	1246	1202	1141

Delivery

Delivery Data: NOVARTIND

#	Date	1402 27% 1780	Value (Cr)	Q/T 8	Del 47	Del 6
1	4-Sep	1647	4	12	74	3
2	3-Sep	1614	3	10	74	2
3	2-Sep	1602	1	7	58	1
4	1-Sep	1582	3	7	43	2
5	31-Aug	1554	5	7	52	3
6	28-Aug	1486	1	8	56	0
7	27-Aug	1490	1	9	62	1
8	26-Aug	1490	1	8	73	1
9	25-Aug	1486	1	9	67	1
10	24-Aug	1502	4	9	51	2
11	21-Aug	1419	4	9	57	2
12	20-Aug	1482	2	9	64	2
13	19-Aug	1532	2	9	68	1
14	18-Aug	1596	1	4	54	0
15	17-Aug	1589	3	8	61	2
16	14-Aug	1582	3	7	60	2
17	13-Aug	1548	2	6	57	1
18	12-Aug	1592	2	8	56	1
19	11-Aug	1594	1	8	59	1
20	10-Aug	1607	1	7	55	1
21	7-Aug	1610	2	7	61	1
22	6-Aug	1610	4	8	48	2
23	5-Aug	1635	1	7	66	1
24	4-Aug	1622	2	7	61	1
25	3-Aug	1636	5	10	65	3
26	31-Jul	1537	4	7	59	3
27	30-Jul	1576	4	5	55	2
28	29-Jul	1596	6	9	79	5
29	28-Jul	1579	4	7	58	2
30	27-Jul	1631	3	7	52	1
31	24-Jul	1641	9	8	41	4
32	23-Jul	1673	37	9	15	5
33	22-Jul	1700	4	11	62	3
34	21-Jul	1702	9	8	41	3
35	20-Jul	1668	7	8	49	3
36	17-Jul	1570	4	8	44	2
37	16-Jul	1596	19	9	21	4
38	15-Jul	1539	8	9	45	4
39	14-Jul	1618	16	10	32	5
40	13-Jul	1665	50	12	23	12
41	10-Jul	1495	3	7	59	2
42	9-Jul	1466	7	9	56	4
43	8-Jul	1452	1	7	67	1
44	7-Jul	1458	1	5	60	0
45	6-Jul	1457	1	5	62	1
46	3-Jul	1469	1	6	63	1
47	2-Jul	1454	4	8	49	2
48	1-Jul	1444	1	6	65	1
49	30-Jun	1434	1	5	61	0
50	29-Jun	1440	1	3	58	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	4,089c	118c	2.96
03-Sep	3,971c	27c	0.69
01-Sep	3,944c	95c	2.46
31-Aug	3,849c	199c	5.44
27-Aug	3,651c	46c	1.26
26-Aug	3,697c	15c	0.40
25-Aug	3,682c	3c	0.09
24-Aug	3,679c	65c	1.80
21-Aug	3,614c	182c	4.80
19-Aug	3,796c	157c	3.97
18-Aug	3,953c	62c	1.59
17-Aug	3,891c	30c	0.77
14-Aug	3,922c	11c	0.28
13-Aug	3,911c	40c	1.01
12-Aug	3,950c	33c	0.83
10-Aug	3,983c	3c	0.08
06-Aug	3,980c	20c	0.49
05-Aug	4,000c	9c	0.24
04-Aug	3,991c	136c	3.52
31-Jul	3,855c	132c	3.32
30-Jul	3,987c	23c	0.58
29-Jul	3,964c	56c	1.42
28-Jul	3,909c	114c	2.82
27-Jul	4,022c	72c	1.75
24-Jul	4,094c	0	0

Stock Checklist

Price is above from 52 week high low average: 85%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 14 fund scheme(s) across 4 fund house(s) as of Aug26 · Total value ₹56 Cr · 8 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	4	0.51%	-0.01%	35.7
Bandhan Mutual Fund	6	0.24%	+0.26%	12.9
Edelweiss Mutual Fund	2	2.01%	-0.13%	7.8
Motilal Oswal Mutual Fund	2	0.00%	+0.01%	0

Novartis India Ltd.

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements